As of June 18, 2025, Calliditas Therapeutics AB (CALTX.ST) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Calliditas Therapeutics AB's Graham Number to Peers
To better understand Calliditas Therapeutics AB's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Calliditas Therapeutics AB (CALTX.ST) | - |
| Camurus AB (CAMX.ST) | 95.64 |
| Oncoarendi Therapeutics SA (OAT.WA) | 32.46 |
| Swedencare AB (publ) (SECARE.ST) | 26.45 |
| IRLAB Therapeutics AB (IRLAB A.ST) | 13.17 |
| Vistin Pharma ASA (VISTN.OL) | 8.86 |
Compared to its competitors, Calliditas Therapeutics AB's Graham Number is difficult to compare due to insufficient data.